UAE HEART FAILURE TREATMENT DRUGS MARKET ANALYSIS

UAE Heart Failure Treatment Drugs MarketSize and Trends

The UAE heart failure treatment drugs market is estimated to be valued at US$ 80.4 million in 2023 and is expected to exhibit a CAGR of 6.5% during the forecast period (2023-2030).

Figure 1. UAE Heart Failure Treatment Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2030

UAE Heart Failure Treatment Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the UAE heart failure treatment drugs market due to nationwide lockdowns. For instance, according to an article published by Heart Views on October 13, 2020, there were some challenges in heart failure care during the pandemic situation. This is because of diagnostic delays, misdiagnosis of COVID-19 in patients with HF due to overlapping symptoms, reduced/disrupted follow up, reduced/no face-to-face contact with clinicians, and difficulty obtaining medication. This reduced the quality of treatment given to heart failure patients in UAE.

UAE Heart Failure Treatment Drugs Market Share (%), By Drug Class, 2023